Related Experiment Video
Updated: Aug 4, 2026

Manufacture of Concentrated, Lipid-based Oxygen Microbubble Emulsions by High Shear Homogenization and Serial Concentration
Published on: May 26, 2014
Concentrate safety and efficacy
1Orthopaedic Hospital, 2400 South Flower Street, Los Angeles, CA 90007, USA. ckasper@laoh.ucla.edu
Abstract:
Safety from transmission of infections through plasma-derived clotting factor concentrates is assured by improved donor screening, serological testing of individual donations and direct viral testing of small plasma pools. Modern viral-inactivation techniques are highly effective. Recombinant concentrates stabilized in human albumin are being superaeded by those with other stabilizers. Recently reported discrepancies between estimates of concentrate potency from in vitro assays versus in vivo recovery, depending upon type of assay and reference standard used, are not fully resolved.
More Related Videos
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Time Course of Drug Effect
Steady State Concentration
Most drugs are administered in repeated doses at fixed intervals or through continuous intravenous...
Dose-Response Relationship: Potency and Efficacy
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Drug Concentrations: Measurements
Plasma —...
Pharmacodynamic Models: Linear Concentration–Effect Model